Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 301-325 of 2,022
RecruitingNCT06642675

nTMS for Negative Symptom in Schizophrenia

This study is comparing Intermittent theta burst stimulation(iTBS) with control group: sham iTBS for people with Schizophrenia. Participants receive Intermittent theta burst stimulation(iTBS) or control group: sham iTBS and complete study visits and assessments.

SchizophreniaOtherUp to 60 Years
Countries
China
Sponsor
Central South University
Condition
Schizophrenia
Not Yet RecruitingNCT07266376

Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS

This study is comparing Integrative group therapy with Media-workshop control group for people with Mental Disorder or Schizophrenia Diagnosis. Participants receive Integrative group therapy or Media-workshop control group and complete study visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de la Guadeloupe
Condition
Schizophrenia
Active Not RecruitingNCT06539780

Imagery Rescripting as a Treatment for Early Psychosis

This study is looking at test the effect of imagery rescripting (ImRs) in early psychosis for people with Psychosis, Schizophrenia, or Psychoses, Traumatic. Participants take part in the program and complete follow-up questionnaires or assessments.

SchizophreniaOtherFrom 16 Years to 45 Years
Countries
Netherlands
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Condition
Schizophrenia
Not Yet RecruitingNCT07252206

A Case Series of Culturally-adapted CBTp for Black People in the UK

This study is looking at whether questionnaires and follow-up can help people with Psychosis or Schizophrenia Spectrum Disorders. Participants take part in the program and complete follow-up questionnaires or assessments.

SchizophreniaOtherOver 16 Years
Countries
United Kingdom
Sponsor
University of Manchester
Condition
Schizophrenia
Not Yet RecruitingNCT06474286

Prucalopride for Cognitive Functioning in Schizophrenia

This study is looking at whether Prucalopride 1 MG can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
India
Sponsor
University of Pittsburgh
Condition
Schizophrenia
Not Yet RecruitingNCT07252752

Dopamine and Insulin in Psychosis

This study is comparing Intranasal Insulin with placebo for people with First Episode Psychosis. Participants receive Intranasal Insulin or placebo and complete study visits and assessments.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
Austria
Sponsor
Medical University of Vienna
Condition
Schizophrenia
Active Not RecruitingNCT05112432

EPI-MINN: Targeting Cognition and Motivation

This study is looking at whether psychoeducation can help people with Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 15 Years to 40 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
RecruitingNCT06581302

Magnetic Seizure Therapy for Psychotic Disorders

This study is looking at whether Magnetic seizure therapy by Magnetic stimulator can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
China
Sponsor
Shanghai Jiao Tong University School of Medicine
Condition
Schizophrenia
Not Yet RecruitingNCT07245212

Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients With First Episode Psychosis (FEP)

This study is looking at whether cognitive behavioural therapy can help people with Psychosis, Cannabis Use Disorder, or First Episode Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
RecruitingNCT07196423

Early Psychosis: Investigating Cognition

This study is looking at whether a digital support tool can help people with First Episode Psychosis or Psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
University of Nottingham
Condition
Schizophrenia
RecruitingNCT07234708

Feeling Safe Study

This study is looking at whether Sentirnos Seguros can help people with Schizophrenia and Schizophrenia Spectrum Psychosis. Participants take part in Sentirnos Seguros and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Condition
Schizophrenia
RecruitingNCT06634641

Clozapine-related Immunodeficiency in Parkinsons Disease

This study is looking at whether blood test can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire, Amiens
Condition
Schizophrenia
RecruitingNCT07230652

A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020

This study is comparing LY03020 with placebo for people with Schizophrenia or Alzheimer's Disease Psychosis. Participants receive LY03020 or placebo and complete study visits and assessments.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
China
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
RecruitingNCT06674694

The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.

This study is looking at whether Brexpiprazole long-acting injection can help people with Schizophrenia Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Condition
Schizophrenia
Active Not RecruitingNCT05968638

Ketogenic Diet in People With Schizophrenia

This study is looking at whether Regular Diet can help people with Schizophrenia or Schizo Affective Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
RecruitingNCT07119268

SPARK Healthy Sleep

This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia and Related Disorders or Sleep Disturbance. Participants take part in the program and complete follow-up questionnaires or assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia
Active Not RecruitingNCT06251193

Optimizing CBSST With Executive Function Training for Schizophrenia

This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia or schizoaffective disorder. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

SchizophreniaOtherOver 60 Years
Countries
Canada, United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
Schizophrenia | Clinical Trials | HopeStage Research